{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:42:50Z","timestamp":1791265370177,"version":"4.1.0"},"reference-count":103,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Advances in Wound Care"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Toxic epidermal necrolysis (TEN) and Steven\u2013Johnson syndrome (SJS) are potentially fatal acute mucocutaneous vesiculobullous disorders. Evidence to date suggests that outcomes for patients with both TEN and SJS are largely dependent on stopping the causative agent, followed by supportive care and appropriate wound management in a specialized burns unit. These are life-threatening conditions characterized by widespread full-thickness cutaneous and mucosal necrosis. This article outlines the approach to holistic management of such patients, in a specialized unit, highlighting various practical aspects of wound care to prevent complications such as infection, mucosal and adhesions, and ocular scaring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Advances:<\/jats:title>\n                    <jats:p>\n                      There is improved understanding of pain and morbidity with regard to the type and frequency of dressing changes. More modern dressings, such as nanocrystalline, are currently favored as they may be kept\n                      <jats:italic toggle=\"yes\">in situ<\/jats:italic>\n                      for longer periods. The most recent evidence on systemic agents, such as corticosteroids and cyclosporine, and novel treatments, are also discussed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical Issues:<\/jats:title>\n                    <jats:p>Following cessation of the culprit trigger, management in a specialized burns unit is the most important management step. It is now understood that a multidisciplinary team is essential in the care of these patients. Following admission of such patients, dermatology, ear, nose, and throat surgery, ophthalmology, urology, colorectal surgery, and gynecology should all be consulted to prevent disease sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Future Directions:<\/jats:title>\n                    <jats:p>Looking forward, research is aimed at achieving prospective data on the efficacy of systemic immunomodulating agents and dressing types. Tertiary centers with burns units should develop policies for such patients to ensure that the relevant teams are consulted promptly to avoid mucocutaneous complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/wound.2019.0977","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T11:34:00Z","timestamp":1576668840000},"page":"426-439","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":105,"title":["Toxic Epidermal Necrolysis and Steven\u2013Johnson Syndrome: A Comprehensive Review"],"prefix":"10.1177","volume":"9","author":[{"given":"Olivia A.","family":"Charlton","sequence":"first","affiliation":[{"name":"Department of Dermatology, Royal North Shore Hospital, Sydney, Australia."},{"name":"Northern Clinical School, University of Sydney, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Prince of Wales Hospital, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Phan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Liverpool Hospital, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Mewton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal North Shore Hospital, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jackson","sequence":"additional","affiliation":[{"name":"Northern Clinical School, University of Sydney, Sydney, Australia."},{"name":"Kolling Institute of Medical Research, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal North Shore Hospital, Sydney, Australia."},{"name":"Northern Clinical School, University of Sydney, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.09.028"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S163391"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(96)00035-2"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780100408"},{"key":"e_1_3_4_7_2","first-page":"43","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis","volume":"126","author":"Chan HL","year":"1990","unstructured":"Chan HL, , Stern RS, , Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol, 1990; 126:43.","journal-title":"A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol"},{"key":"e_1_3_4_8_2","first-page":"839","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"127","author":"Sch\u00f6pf E","year":"1991","unstructured":"Sch\u00f6pf E, , St\u00fchmer A, , Rzany B, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol, 1991; 127:839.","journal-title":"An epidemiologic study from West Germany. Arch Dermatol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.01.031"},{"key":"e_1_3_4_10_2","first-page":"37","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"126","author":"Roujeau JC","year":"1990","unstructured":"Roujeau JC, , Guillaume JC, , Fabre JP, et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985. Arch Dermatol, 1990; 126:37\u201342.","journal-title":"Incidence and drug etiology in France, 1981\u20131985. Arch Dermatol"},{"key":"e_1_3_4_11_2","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea","volume":"11","author":"Yang MS","year":"2016","unstructured":"Yang MS, , Lee JY, , Kim J, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea. PLoS One, 2016; 11:e0165933.","journal-title":"PLoS One"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.510"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.03.023"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122135"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013297"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2016.12.001"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-209102"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-263X.2004.00515.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12253"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200102000-00022"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0169"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.83.216"},{"key":"e_1_3_4_25_2","first-page":"466","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis","volume":"129","author":"Correia O","year":"1993","unstructured":"Correia O, , Delgado L, , Ramos JP, et al. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. Arch Dermatol, 1993; 129:466.","journal-title":"Further evidence of CD8+ lymphocyte involvement. Arch Dermatol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0158-0"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.08.013"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13430"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.034"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.07.047"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.10.015"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.120563"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01176.x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.04.048"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1997.tb02524.x"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6141"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13172"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20196864"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1995.01690230046008"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.09.029"},{"key":"e_1_3_4_41_2","first-page":"153","article-title":"Vulvovaginal sequelae in toxic epidermal necrolysis","volume":"42","author":"Meneux E","year":"1997","unstructured":"Meneux E, , Paniel BJ, , Pouget F, et al. Vulvovaginal sequelae in toxic epidermal necrolysis. J Reprod Med, 1997; 42:153\u2013156.","journal-title":"J Reprod Med"},{"key":"e_1_3_4_42_2","first-page":"1160","article-title":"Toxic epidermal necrolysis","volume":"123","author":"Revuz J","year":"1987","unstructured":"Revuz J, , Penso D, , Roujeau JC, et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol, 1987; 123:1160\u20131165.","journal-title":"Clinical findings and prognosis factors in 87 patients. Arch Dermatol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2017.01.018"},{"key":"e_1_3_4_44_2","first-page":"187","article-title":"Toxic epidermal necrolysis: part II","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, , McDonough PH, , Lee BW. Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol, 2013; 69:187.e1\u2013187.e16.","journal-title":"Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1971.00770060069007"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182a51f06"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050492"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2015.12.011"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23537"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.048"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225861"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070938"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.10.029"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2015.09.001"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14488"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181773d5d"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.1258"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2007.04184.x"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/BCR.0b013e318236fe31"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/WON.0000000000000287"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2007.07.014"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2007.06.008"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.032"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1884"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.04.007"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198611000-00001"},{"key":"e_1_3_4_67_2","first-page":"782","article-title":"Suppression of TNF-alpha-induced cell death","volume":"274","author":"Van Antwerp DJ","year":"1996","unstructured":"Van Antwerp DJ, , Martin SJ, , Kafri T, et al. Suppression of TNF-alpha-induced cell death. Science, 1996; 274:782\u2013784.","journal-title":"Science"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.039"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30811-1"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06721.x"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2595372"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09863.x"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5668"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.490"},{"key":"e_1_3_4_75_2","first-page":"26","article-title":"Treatment of toxic epidermal necrolyis with high-dose intravenous imunoglobulins","volume":"139","author":"Prins C","year":"2003","unstructured":"Prins C, , Kerdel F, , Padilla S, et al. Treatment of toxic epidermal necrolyis with high-dose intravenous imunoglobulins. Multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol, 2003; 139:26\u201332.","journal-title":"Multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.1.39"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10965.x"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.014"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02197-7"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.46833.x"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.04.044"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418758989"},{"key":"e_1_3_4_84_2","first-page":"e15","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis","volume":"101","author":"Woolridge KF","year":"2018","unstructured":"Woolridge KF, , Boler PL, , Lee BD. Tumour necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis. Cutis, 2018; 101:e15\u2013e21.","journal-title":"Cutis"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06925.x"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09585.x"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb01167.x"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2016.06.003"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/PSN.0000000000000234"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12397"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.02.120"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1159\/000430957"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12343"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.11.1479"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12361"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13837"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8798"},{"key":"e_1_3_4_98_2","first-page":"11142","article-title":"Pigment epithelium-derived factor (PEDF) as a regulator of wound angiogenesis","volume":"8","author":"Michalczyk E","year":"2018","unstructured":"Michalczyk E, , Chen L, , Fine D, et al. Pigment epithelium-derived factor (PEDF) as a regulator of wound angiogenesis. Nat Sci Rep, 2018; 8:11142.","journal-title":"Nat Sci Rep"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.01.010"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200003000-00017"},{"key":"e_1_3_4_101_2","first-page":"24","article-title":"Cyclosporine for SJS\/TEN: a case series and review of the literature","volume":"87","author":"Reese D","year":"2011","unstructured":"Reese D, , Henning JS, , Rockers K, et al. Cyclosporine for SJS\/TEN: a case series and review of the literature. Cutis, 2011; 87:24.","journal-title":"Cutis"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.116738"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.07.016"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.048"}],"container-title":["Advances in Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/wound.2019.0977","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/wound.2019.0977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/wound.2019.0977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:14:27Z","timestamp":1773238467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/wound.2019.0977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1089\/wound.2019.0977"],"URL":"https:\/\/doi.org\/10.1089\/wound.2019.0977","relation":{},"ISSN":["2162-1918","2162-1934"],"issn-type":[{"value":"2162-1918","type":"print"},{"value":"2162-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]}}}